{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:58:57Z","timestamp":1781060337169,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00520-026-10793-w","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:53:55Z","timestamp":1779497635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of metabolic markers, inflammatory biomarkers, and sedentary time with comorbidities among cancer patients: Results from NHANES 2021\u20132023"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1426-9558","authenticated-orcid":false,"given":"Mihee","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9221-0405","authenticated-orcid":false,"given":"Junga","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"issue":"3","key":"10793_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10793_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL et al (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"10793_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102833","author":"M Tregear","year":"2024","unstructured":"Tregear M, Visco F (2024) Outcomes that matter to patients with cancer: living longer and living better. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102833","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10793_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.trecan.2020.12.010","volume":"7","author":"G Panigrahi","year":"2021","unstructured":"Panigrahi G, Ambs S (2021) How comorbidities shape cancer biology and survival. Trends Cancer 7(6):488\u2013495. https:\/\/doi.org\/10.1016\/j.trecan.2020.12.010","journal-title":"Trends Cancer"},{"issue":"4","key":"10793_CR5","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/cncr.33981","volume":"128","author":"C Jiang","year":"2022","unstructured":"Jiang C et al (2022) Chronic comorbid conditions among adult cancer survivors in the United States: results from the National Health Interview Survey, 2002\u20102018. Cancer 128(4):828\u2013838. https:\/\/doi.org\/10.1002\/cncr.33981","journal-title":"Cancer"},{"key":"10793_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S229935","author":"MA Luque-Fernandez","year":"2020","unstructured":"Luque-Fernandez MA et al (2020) Multimorbidity by patient and tumor factors and time-to-surgery among colorectal cancer patients in Spain: a population-based study. Clin Epidemiol. https:\/\/doi.org\/10.2147\/CLEP.S229935","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10793_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/carcin\/bgaa121","volume":"42","author":"TZ Minas","year":"2021","unstructured":"Minas TZ et al (2021) An overview of cancer health disparities: new approaches and insights and why they matter. Carcinogenesis 42(1):2\u201313. https:\/\/doi.org\/10.1093\/carcin\/bgaa121","journal-title":"Carcinogenesis"},{"issue":"7","key":"10793_CR8","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/pon.5632","volume":"30","author":"D Petrova","year":"2021","unstructured":"Petrova D et al (2021) Physical comorbidities as a marker for high risk of psychological distress in cancer patients. Psychooncology 30(7):1160\u20131166. https:\/\/doi.org\/10.1002\/pon.5632","journal-title":"Psychooncology"},{"issue":"4","key":"10793_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","volume":"66","author":"D Sarfati","year":"2016","unstructured":"Sarfati D, Koczwara B, Jackson C (2016) The impact of comorbidity on cancer and its treatment. CA Cancer J Clin 66(4):337\u2013350. https:\/\/doi.org\/10.3322\/caac.21342","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10793_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12889-024-17855-w","volume":"24","author":"Z Xiang","year":"2024","unstructured":"Xiang Z, Wang H, Li H (2024) Comorbidity risk and distribution characteristics of chronic diseases in the elderly population in China. BMC Public Health 24(1):360. https:\/\/doi.org\/10.1186\/s12889-024-17855-w","journal-title":"BMC Public Health"},{"key":"10793_CR11","doi-asserted-by":"publisher","unstructured":"Azad GAA, et al (2024) Co-Morbidity Landscape in Cancer Patients: Non-Communicable Disease Burden and Trends. Asia Pacific J Med Innovations 1(2) 48\u201354. https:\/\/doi.org\/10.70818\/apjmi.2024.v01i02.08","DOI":"10.70818\/apjmi.2024.v01i02.08"},{"issue":"4","key":"10793_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1634\/theoncologist.2017-0404","volume":"23","author":"GR Williams","year":"2018","unstructured":"Williams GR et al (2018) Patient\u2010reported comorbidity and survival in older adults with cancer. Oncologist 23(4):433\u2013439. https:\/\/doi.org\/10.1634\/theoncologist.2017-0404","journal-title":"Oncologist"},{"issue":"8","key":"10793_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2522\/ptj.20090278","volume":"90","author":"J Blaney","year":"2010","unstructured":"Blaney J et al (2010) The cancer rehabilitation journey: barriers to and facilitators of exercise among patients with cancer-related fatigue. Phys Ther 90(8):1135\u20131147. https:\/\/doi.org\/10.2522\/ptj.20090278","journal-title":"Phys Ther"},{"issue":"3","key":"10793_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/1878-0261.12772","volume":"15","author":"CM Friedenreich","year":"2021","unstructured":"Friedenreich CM, Ryder\u2010Burbidge C, McNeil J (2021) Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncol 15(3):790\u2013800. https:\/\/doi.org\/10.1002\/1878-0261.12772","journal-title":"Mol Oncol"},{"issue":"4","key":"10793_CR15","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1152\/physrev.00022.2022","volume":"103","author":"AJ Pinto","year":"2023","unstructured":"Pinto AJ et al (2023) Physiology of sedentary behavior. Physiol Rev 103(4):2561\u20132622. https:\/\/doi.org\/10.1152\/physrev.00022.2022","journal-title":"Physiol Rev"},{"key":"10793_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.canep.2018.12.006","volume":"58","author":"M Kim","year":"2019","unstructured":"Kim M et al (2019) Increased prevalence of metabolic syndrome in adult cancer survivors: Asian first report in community setting. Cancer Epidemiol 58:130\u2013136. https:\/\/doi.org\/10.1016\/j.canep.2018.12.006","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10793_CR17","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","volume":"38","author":"JL Silveira Rossi","year":"2022","unstructured":"Silveira Rossi JL et al (2022) Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev 38(3):e3502. https:\/\/doi.org\/10.1002\/dmrr.3502","journal-title":"Diabetes Metab Res Rev"},{"key":"10793_CR18","unstructured":"Swarup S, et al (2024) Metabolic syndrome, in StatPearls [internet]. 2024, StatPearls Publishing"},{"key":"10793_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.02.003","volume":"259","author":"Y Li","year":"2017","unstructured":"Li Y et al (2017) Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis 259:75\u201382. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.02.003","journal-title":"Atherosclerosis"},{"issue":"1","key":"10793_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/cancers15010257","volume":"15","author":"R Minici","year":"2022","unstructured":"Minici R et al (2022) Prognostic role of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-C reactive protein ratio (LCR) in patients with hepatocellular carcinoma (HCC) undergoing chemoembolizations (TACE) of the liver: the unexplored corner linking tumor microenvironment, biomarkers and interventional radiology. Cancers 15(1):257. https:\/\/doi.org\/10.3390\/cancers15010257","journal-title":"Cancers"},{"key":"10793_CR21","doi-asserted-by":"publisher","unstructured":"Saini A et al (2020) Cancer causes and treatments. Int J Pharm Sci Res 11(7) 3121\u20133134. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.11(7).3121-34","DOI":"10.13040\/IJPSR.0975-8232.11(7).3121-34"},{"key":"10793_CR22","doi-asserted-by":"publisher","first-page":"101962","DOI":"10.1016\/j.canep.2021.101962","volume":"73","author":"E Michalopoulou","year":"2021","unstructured":"Michalopoulou E et al (2021) Impact of comorbidities at diagnosis on the 10-year colorectal cancer net survival: a population-based study. Cancer Epidemiol 73:101962. https:\/\/doi.org\/10.1016\/j.canep.2021.101962","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"10793_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1200\/JCO.2016.67.1883","volume":"35","author":"CM Alfano","year":"2017","unstructured":"Alfano CM et al (2017) Inflammatory cytokines and comorbidity development in breast cancer survivors versus noncancer controls: evidence for accelerated aging? J Clin Oncol 35(2):149\u2013156. https:\/\/doi.org\/10.1200\/JCO.2016.67.1883","journal-title":"J Clin Oncol"},{"issue":"2","key":"10793_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaccao.2022.03.005","volume":"4","author":"LL Zullig","year":"2022","unstructured":"Zullig LL et al (2022) Cardiometabolic comorbidities in cancer survivors: JACC: CardioOncology state-of-the-art review. Cardio Oncology 4(2):149\u2013165. https:\/\/doi.org\/10.1016\/j.jaccao.2022.03.005","journal-title":"Cardio Oncology"},{"issue":"18","key":"10793_CR25","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1200\/JCO.2016.71.9716","volume":"35","author":"GP Guy Jr","year":"2017","unstructured":"Guy GP Jr et al (2017) Economic burden of chronic conditions among survivors of cancer in the United States. J Clin Oncol 35(18):2053\u20132061. https:\/\/doi.org\/10.1200\/JCO.2016.71.9716","journal-title":"J Clin Oncol"},{"key":"10793_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103274","author":"Q Li","year":"2025","unstructured":"Li Q et al (2025) Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis. EClinicalMedicine. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103274","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10793_CR27","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1111\/ajco.12677","volume":"14","author":"HS Ng","year":"2018","unstructured":"Ng HS et al (2018) Comorbidity, physical and mental health among cancer patients and survivors: an Australian population\u2010based study. Asia\u2010Pacific J Clin Oncol 14(2):e181\u2013e192. https:\/\/doi.org\/10.1111\/ajco.12677","journal-title":"Asia\u2010Pacific J Clin Oncol"},{"issue":"4","key":"10793_CR28","doi-asserted-by":"publisher","first-page":"e26425","DOI":"10.2196\/26425","volume":"7","author":"M George","year":"2021","unstructured":"George M et al (2021) Physical comorbidities and their relationship with cancer treatment and its outcomes in older adult populations: systematic review. JMIR cancer 7(4):e26425. https:\/\/doi.org\/10.2196\/26425","journal-title":"JMIR cancer"},{"key":"10793_CR29","doi-asserted-by":"publisher","first-page":"105737","DOI":"10.1016\/j.jsbmb.2020.105737","volume":"203","author":"D Dhawan","year":"2020","unstructured":"Dhawan D, Sharma S (2020) Abdominal obesity, adipokines and non-communicable diseases. J Steroid Biochem Mol Biol 203:105737. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105737","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10793_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103264","author":"E Fryk","year":"2021","unstructured":"Fryk E et al (2021) Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: a mechanistic case-control and a population-based cohort study. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103264","journal-title":"EBioMedicine"},{"issue":"9","key":"10793_CR31","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.2337\/dc20-2252","volume":"44","author":"MH Yamada","year":"2021","unstructured":"Yamada MH et al (2021) Associations of systolic blood pressure and diastolic blood pressure with the incidence of coronary artery disease or cerebrovascular disease according to glucose status. Diabetes Care 44(9):2124\u20132131. https:\/\/doi.org\/10.2337\/dc20-2252","journal-title":"Diabetes Care"},{"issue":"2","key":"10793_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/jech-2018-211433","volume":"73","author":"Y Dong","year":"2019","unstructured":"Dong Y et al (2019) High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study. J Epidemiol Community Health 73(2):188\u2013192. https:\/\/doi.org\/10.1136\/jech-2018-211433","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"10793_CR33","doi-asserted-by":"publisher","first-page":"532","DOI":"10.5935\/2359-4802.20180038","volume":"31","author":"HO Santos","year":"2018","unstructured":"Santos HO, Izidoro LFM (2018) Neutrophil-lymphocyte ratio in cardiovascular disease risk assessment. Int J Cardiovasc Sci 31(5):532\u2013537. https:\/\/doi.org\/10.5935\/2359-4802.20180038","journal-title":"Int J Cardiovasc Sci"},{"issue":"7","key":"10793_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0290805","volume":"19","author":"S Yuan","year":"2024","unstructured":"Yuan S et al (2024) The relationship between NLR, LDL-C\/HDL-C, NHR and coronary artery disease. PLoS ONE 19(7):e0290805. https:\/\/doi.org\/10.1371\/journal.pone.0290805","journal-title":"PLoS ONE"},{"issue":"1","key":"10793_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2703518","volume":"2018","author":"T Angkananard","year":"2018","unstructured":"Angkananard T et al (2018) Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta\u2010analysis. BioMed Res Int 2018(1):2703518. https:\/\/doi.org\/10.1155\/2018\/2703518","journal-title":"BioMed Res Int"},{"issue":"1","key":"10793_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7796727","volume":"2021","author":"H Yaribeygi","year":"2021","unstructured":"Yaribeygi H et al (2021) Pathophysiology of physical inactivity\u2010dependent insulin resistance: a theoretical mechanistic review emphasizing clinical evidence. J Diabetes Res 2021(1):7796727. https:\/\/doi.org\/10.1155\/2021\/7796727","journal-title":"J Diabetes Res"},{"issue":"5","key":"10793_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10654-022-00873-6","volume":"37","author":"R Hermelink","year":"2022","unstructured":"Hermelink R et al (2022) Sedentary behavior and cancer\u2013an umbrella review and meta-analysis. Eur J Epidemiol 37(5):447\u2013460. https:\/\/doi.org\/10.1007\/s10654-022-00873-6","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"10793_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky073","volume":"2","author":"LH Nguyen","year":"2018","unstructured":"Nguyen LH et al (2018) Sedentary behaviors, TV viewing time, and risk of young-onset colorectal cancer. JNCI Cancer Spectr 2(4):p. pky073. https:\/\/doi.org\/10.1093\/jncics\/pky073","journal-title":"JNCI Cancer Spectr"},{"issue":"6","key":"10793_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4082\/kjfm.20.0165","volume":"41","author":"JH Park","year":"2020","unstructured":"Park JH et al (2020) Sedentary lifestyle: overview of updated evidence of potential health risks. Korean J Fam Med 41(6):365. https:\/\/doi.org\/10.4082\/kjfm.20.0165","journal-title":"Korean J Fam Med"},{"key":"10793_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijcard.2019.01.038","volume":"280","author":"M Totzeck","year":"2019","unstructured":"Totzeck M et al (2019) Cardio-oncology-strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol 280:163\u2013175. https:\/\/doi.org\/10.1016\/j.ijcard.2019.01.038","journal-title":"Int J Cardiol"},{"issue":"4","key":"10793_CR41","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/icb.2016.126","volume":"95","author":"K Nakamura","year":"2017","unstructured":"Nakamura K, Smyth MJ (2017) Targeting cancer-related inflammation in the era of immunotherapy. Immunol Cell Biol 95(4):325\u2013332. https:\/\/doi.org\/10.1038\/icb.2016.126","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10793_CR42","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/jcsm.13443","volume":"15","author":"K Ueno","year":"2024","unstructured":"Ueno K et al (2024) Metabolic syndrome and cardiovascular disease in cancer survivors. J Cachexia Sarcopenia Muscle 15(3):1062\u20131071. https:\/\/doi.org\/10.1002\/jcsm.13443","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10793-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10793-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10793-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:29:39Z","timestamp":1781058579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10793-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10793"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10793-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}